New Key Statistics Module, Z-Score and F-Score
FRA:CYTH Key Ratios
| Market Cap € M | 1,297.00 |
| Enterprise Value € M | 18,213.35 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 3.29 |
| Price/Sales | 0.09 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) € M | 13,507.00 |
| EPS (TTM) € | -9.65 |
| Beneish M-Score | -2.9 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -274.50 |
| EV-to-EBIT | -2.14 |
| EV-to-EBITDA | -3.18 |
| PEG | -- |
| Shares Outstanding M | 1,016.01 |
| Net Margin (%) | -70.74 |
| Operating Margin % | 8.45 |
| Pre-tax Margin (%) | -70.32 |
| Quick Ratio | 1.29 |
| Current Ratio | 1.35 |
| ROA % (ttm) | -26.10 |
| ROE % (ttm) | -195.86 |
| ROIC % (ttm) | 3.41 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.12 |
FRA:CYTH Number of Guru Trades
FRA:CYTH Volume of Guru Trades
Gurus Latest Trades with FRA:CYTH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
FRA:CYTH is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers